Neonatal Blood Pressure Regulation

Seminars in Perinatology

Volumn 28, Issue 2, 2004, Pages 141-148

  Jones, John Edward ^a   Jose, Pedro A ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; CAPTOPRIL; CORTICOSTEROID; DOBUTAMINE; DOPAMINE; ENALAPRIL; ENALAPRILAT; G PROTEIN COUPLED RECEPTOR KINASE 2; NICARDIPINE;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; CARDIOVASCULAR AUTOREGULATION; DRUG CONTRAINDICATION; FLUID THERAPY; HUMAN; HYPERTENSION; HYPOTENSION; NEWBORN; PATHOPHYSIOLOGY; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SYSTOLIC BLOOD PRESSURE;

EID: 2342451912     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semperi.2003.11.004     Document Type: Article

References (58)

1. Chobanian AV, Bakris GL, Black HR, et al: The seventh report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 289:2560-2572, 2003
2. Nuntnarumit P, Yang W, Bada-Ellzey HS: Blood pressure measurements in the newborn. Clin Perinatol 26:981-996, 1999
3. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents: Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents. A working group report from the National High Blood Pressure Education Program. Pediatrics 98:649-658, 1996
4. Barker ME, Shiell AW, Law CM: Evaluation of the Dinamap 8100 and Omron M1 blood pressure monitors for use in children. Paediatr Perinat Epidemiol 14:179-186, 2000
5. Guyton AC: Arterial Pressure and Hypertension, Philadelphia, PA, Saunders, 1980
6. Tibby SM, Murdoch IA: Monitoring cardiac function in intensive care. Arch Dis Child 88:46-52, 2003
7. Reber KM, Nankervis CA, Nowicki PT: Newborn intestinal circulation. Physiology and pathophysiology. Clin Perinatol 29:23-39, 2002
8. Yanowitz TD, Yao AC, Pettigrew KD, et al: Postnatal hemodynamic changes in very-low-birthweight infants. J Appl Physiol 87:370-380, 1999
9. Watkins AM, West CR, Cooke RW: Blood pressure and cerebral haemorrhage and ischaemia in very low birth-weight infants. Early Hum Dev 19:103-110, 1989
10. Goonasekera CD, Dillon MJ: Measurement and interpretation of blood pressure. Arch Dis Child 82:261-265, 2000
11. Watkinson M: Hypertension in the newborn baby. Arch Dis Child Fetal Neonatal Ed 86:F78-F81, 2002
12. Flynn JT: Neonatal hypertension: diagnosis and management. Pediatr Nephrol 14:332-341, 2000
13. Milou C, Debuche-Benouachkou V, Semama DS, et al: Intravenous nicardipine as a first-line antihypertensive drug in neonates. Intensive Care Med 26:956-958, 2000
14. Gilboa N, Urizar RE: Severe hypertension in newborn after pyeloplasty of hydronephrotic kidney. Urology 22: 179-82, 1983
15. Al-Aweel I, Pursley DM, Rubin LP, et al: Variations in prevalence of hypotension, hypertension, and vasopressor use in NICUs. J Perinatol 21:272-278, 2001
16. Seri I: Circulatory support of the sick preterm infant. Semin Neonatol 6:85-95, 2001
17. Kluckow M, Evans N: Low systemic blood flow in the preterm infant. Semin Neonatol 6:75-84, 2001
18. Evans N, Kluckow M, Simmons M, et al: Which to measure, systemic or organ blood flow? Middle cerebral artery and superior vena cava flow in very preterm infants. Arch Dis Child Fetal Neonatal Ed 87:F181-F184, 2002
19. Osborn D, Evans N, Kluckow M: Randomized trial of dobutamine versus dopamine in preterm infants with low systemic blood flow. J Pediatr 140:183-191, 2002
20. Goodman and Gilman's: The Pharmacological Basis of Therapeutics (ed 10), in Goodman, LS, Limbird LE, Milinoff PB, et al (eds): New York, NY, McGraw-Hill, 1996
21. Alexander S, Mathie A, Peters J, et al: TiPS 12th Edition Nomenclature Supplement, Londonpp1-146, Current Trends, 2001
22. Rokosh DG, Simpson PC: Knockout of the α1A/C-adrenergic receptor subtype: the alpha 1A/C is expressed in resistance arteries and is required to maintain arterial blood pressure. Proc Natl Acad Sci USA 99:9474-9479, 2002
23. 1-adrenergic receptor subtype function. Life Sci 71:2207-2215, 2002
24. 1B-adrenoceptors in mouse. Physiol Genomics 9:85-91, 2002
25. Chruscinski AJ, Rohrer DK, Schauble E, et al: Targeted disruption of the β2 adrenergic receptor gene. J Biol Chem 274:16694-16700, 1999
26. Rohrer DK, Chruscinski A, Schauble EH, et al: Cardiovascular and metabolic alterations in mice lacking both β1-and β2-adrenergic receptors. J Biol Chem 274:16701-16708, 1999
27. 3-adrenoceptor knockout mice are obese and cold-sensitive but have normal lipolytic responses to fasting. FEBS Lett 530:37-40, 2002
28. Small KM, Wagoner LE, Levin AM, et al: Synergistic polymorphisms of β1- and α2C-adrenergic receptors and the risk of congestive heart failure. N Engl J Med 347: 1135-1142, 2002
29. Ozono R, O'Connell DP, Wang ZQ, et al: Localization of the dopamine D1 receptor protein in the human heart and kidney. Hypertension 30:725-729, 1997
30. Habuchi Y, Tanaka H, Nishio M, et al: M. Dopamine stimulation of cardiac β-adrenoceptors: the involvement of sympathetic amine transporters and the effect of SKF38393. Br J Pharmacol 122:1669-1678, 1997
31. Jose PA, Eisner GM, Felder RA: Dopamine and the kidney: Role in hypertension? Curr Opin Nephrol Hypertens 12:189-194, 2003
32. Felder RA, Sanada H, Xu J, et al: G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc Natl Acad Sci USA 99:3872-3877, 2002
33. Jose PA, Eisner GM, Felder RA: The renal dopamine receptors in health and hypertension. Pharmacol Ther 80:149-182, 1998
34. Eckhart AD, Ozaki T, Tevaearai H, et al: Vascular-targeted overexpression of G protein-coupled receptor kinase-2 in transgenic mice attenuates beta-adrenergic receptor signaling and increases resting blood pressure. Mol Pharmacol 261:749-758, 2002
35. Kohout TA, Lefkowitz RJ: Regulation of G protein-coupled receptor kinases and arrestins during receptor desensitization. Mol Pharmacol 63:9-18, 2003
36. Bengra C, Mifflin TE, Khripin Y, et al: Genotyping essential hypertension SNPs using a homogenous PCR method with universal energy transfer primers. Clin Chem 48:2131-140, 2002
37. Anwar MA, Ju K, Docherty CC, et al: Developmental changes in reactivity of small femoral arteries in the fetal and postnatal baboon. Am J Obstet Gynecol 184:707-712, 2001
38. Nakanishi T, Kamata K, Nojima K, et al: Inotropic effect of phenylephrine and myocardial α-adrenergic receptor in newborn and adult animals. J Mol Cell Cardiol 21: 975-985, 1989
39. McCormack J, Gelband H, Villafane J, et al: In vivo demonstration of maturational changes of the chronotropic response to α-adrenergic stimulation. Pediatr Res 24:50-54, 1988
40. Jose P, Slotkoff L, Lilienfield L, et al: Sensitivity of the neonatal renal vasculature to epinephrine. Am J Physiol 226:796-799, 1974
41. Longo LD, Ueno N, Zhao Y, et al: Developmental changes in alpha 1-adrenergic receptors, IP3 responses, and NE-induced contraction in cerebral arteries. Am J Physiol 271:H2313-H2319, 1996
42. Felder RA, Calcagno PL, Eisner GM, et al: Ontogeny of myocardial adrenoceptors II. Alpha adrenoceptors. Pediatr Res 16:340-342, 1982
43. Shen H, Peri KG, Deng XF, et al: Distribution of α1-adrenoceptor subtype proteins in different tissues of neonatal and adult rats. Can J Physiol Pharmacol 78:237-243, 2000
44. Slotkin TA, Lau C, Seidler FJ: β-adrenergic receptor overexpression in the fetal rat: distribution, receptor subtypes, and coupling to adenylate cyclase activity via G-proteins. Toxicol Appl Pharmacol 129:223-234, 1994
45. Sun LS: Regulation of myocardial β-adrenergic receptor function in adult and neonatal rabbits. Biol Neonate 76:181-192, 1999
46. Whitsett JA, Noguchi A, Moore JJ: Developmental aspects of α- and β-adrenergic receptors. Semin Perinatol 6:125-141, 1982
47. Auman JT, Seidler FJ, Slotkin TA: β-adrenoceptor control of G protein function in the neonate: determinant of desensitization or sensitization. Am J Physiol Regul Integr Comp Physiol 283:R1236-R1244, 2002
48. Nakamura KT, Alden BM, Matherne GP, et al: Ontogeny of renal hemodynamic response to terbutaline and forskoline in sheep. J Pharmacol Exp Ther 247:453-459, 1988
49. Felder RA, Jose PA: Development of adrenergic and dopamine receptors in the kidney, in Strauss J (ed): Homeostasis, Nephrotoxicity, and Renal Anomalies in the Newborn Boston, Martinus-Nijhoff, 1986, pp 3-10
50. Lundstrom K, Pryds O, Greisen G: The haemodynamic effects of dopamine and volume expansion in sick preterm infants. Early Hum Dev 57:157-163, 2000
51. Nguyen LB, Lievano G, Radhakrishnan J, et al: Renal effects of low to moderate doses of dopamine in newborn piglets. J Pediatr Surg 34:996-999, 1999
52. Pearson RJ, Barrington KJ, Jirsch DW, et al: Dopaminergic receptor-mediated effects in the mesenteric vasculature and renal vasculature of the chronically instrumented newborn piglet. Crit Care Med 24:1706-1712, 1996
53. Pelayo JC, Fildes RD, Jose PA: Age-dependent renal effects of intrarenal dopamine infusion. Am J Physiol 247:R212-R216, 1984
54. Felder RA, Felder CC, Eisner GM, et al: The dopamine receptor in adult and maturing kidney. Am J Physiol 257:F315-F327, 1989
55. Chin A, O'Conner LN, Radhakrishnan J, et al: Endotoxemia and the effects of dopamine on renal functions of neonatal piglets. Biol Neonate 81:196-202, 2002
56. Yoder B, Martin H, McCurnin DC, et al: Impaired urinary cortisol excretion and early cardiopulmonary dysfunction in immature baboons. Pediatr Res 51:426-432, 2002
57. Seri I, Tan R, Evans J: Cardiovascular effects of hydrocortisone in preterm infants with pressor-resistant hypotension. Pediatrics 107:1070-1074, 2001
58. Bourchier D, Weston PJ: Randomized trial of dopamine compared with hydrocortisone for the treatment of hypotensive very low birthweight infants. Arch Dis Child 76:F174-F178, 1997